ATP2C2 antisense RNA 1 (ATP2C2-AS1)

ATP2C2 antisense RNA 1 (ATP2C2-AS1) is a long non-coding antisense RNA gene located on human chromosome 16. As a member of the lncRNA class, its transcripts act in an antisense orientation to the protein-coding gene ATP2C2. ATP2C2-AS1 does not encode protein but may modulate the expression or function of ATP2C2 or other nearby genes, potentially affecting processes such as ion transport or cellular calcium/magnesium homeostasis. In addition, some evidence suggests altered ATP2C2-AS1 expression is associated with cancer prognosis (as in thyroid carcinoma), consistent with a broader role for antisense lncRNAs in cancer biology via regulation of gene expression, translation, or mRNA stability[2][3][4][5][6]. There is no evidence that ATP2C2-AS1 is a direct therapeutic target, nor are there known drugs targeting it. It is primarily of current interest for research into gene regulation and as a potential marker for certain disease states. ATP2C2-AS1 should not be confused with the protein-coding gene ATP2C2 ("ATPase secretory pathway Ca2+ transporting 2"), which is a calcium ATPase[1] and has been studied as an immune and cancer-related marker[7]. The functional roles of ATP2C2-AS1 specifically, as distinct from general antisense lncRNA mechanisms, remain incompletely characterized in the current literature[2][6].

Other names

RP11-517C16.2-001RP11-517C16.2ATP2C2-AS1